Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| MDT | Kiil Harry Skip | EVP & President Cardiovascular | 09/16/2026 | Verkauf | 93.65 | 1,483 | 138,883 | Form 4 |
| MDT | Blomquist Denise L. | Chief Accounting Officer | 09/15/2026 | Schenkung | — | 600 | — | Form 4 |
| MDAI | DiMaio John Michael | Director | 09/11/2026 | Zuteilung | 1.59 | 22,000 | 34,980 | Form 4 |
| MDGL | Sibold William John | President and CEO | 09/11/2026 | Verkauf | 546.38 | 120 | 65,565 | Form 4 |
| MDGL | Sibold William John | President and CEO | 09/11/2026 | Verkauf | 544.83 | 761 | 414,616 | Form 4 |
| MDGL | Sibold William John | President and CEO | 09/11/2026 | Verkauf | 544.02 | 1,539 | 837,253 | Form 4 |
| MDGL | Sibold William John | President and CEO | 09/11/2026 | Verkauf | 542.60 | 1,202 | 652,209 | Form 4 |
| MDGL | Sibold William John | President and CEO | 09/11/2026 | Verkauf | 541.64 | 368 | 199,324 | Form 4 |
| MDGL | Sibold William John | President and CEO | 09/11/2026 | Verkauf | 540.59 | 687 | 371,382 | Form 4 |
| MDGL | Sibold William John | President and CEO | 09/11/2026 | Verkauf | 537.62 | 160 | 86,019 | Form 4 |
| MDGL | Sibold William John | President and CEO | 09/11/2026 | Verkauf | 535.94 | 218 | 116,836 | Form 4 |
| MDGL | Sibold William John | President and CEO | 09/11/2026 | Verkauf | 534.06 | 106 | 56,611 | Form 4 |
| MDGL | Sibold William John | President and CEO | 09/11/2026 | Verkauf | 533.09 | 60 | 31,985 | Form 4 |
| MDAI | DiMaio John Michael | Director | 09/10/2026 | Zuteilung | 1.56 | 10,000 | 15,600 | Form 4 |
| MD | Linynsky Laura A | Director | 09/10/2026 | Abgabe | 26.82 | 6,000 | 160,920 | Form 4 |
| MDGL | Sibold William John | President and CEO | 09/09/2026 | Verkauf | 542.55 | 160 | 86,808 | Form 4 |
| MDGL | Sibold William John | President and CEO | 09/09/2026 | Verkauf | 541.65 | 362 | 196,079 | Form 4 |
| MDGL | Sibold William John | President and CEO | 09/09/2026 | Verkauf | 540.19 | 505 | 272,796 | Form 4 |
| MDGL | Sibold William John | President and CEO | 09/09/2026 | Verkauf | 539.03 | 215 | 115,891 | Form 4 |
| MDGL | Sibold William John | President and CEO | 09/09/2026 | Verkauf | 538.30 | 520 | 279,914 | Form 4 |
| MDGL | Sibold William John | President and CEO | 09/09/2026 | Verkauf | 537.17 | 640 | 343,791 | Form 4 |
| MDGL | Sibold William John | President and CEO | 09/09/2026 | Verkauf | 536.11 | 1,040 | 557,557 | Form 4 |
| MDGL | Sibold William John | President and CEO | 09/09/2026 | Verkauf | 535.27 | 644 | 344,715 | Form 4 |
| MDGL | Sibold William John | President and CEO | 09/09/2026 | Verkauf | 534.20 | 396 | 211,542 | Form 4 |
| MDGL | Sibold William John | President and CEO | 09/09/2026 | Verkauf | 533.09 | 512 | 272,944 | Form 4 |
| MDGL | Sibold William John | President and CEO | 09/09/2026 | Verkauf | 531.99 | 368 | 195,772 | Form 4 |
| MDGL | Sibold William John | President and CEO | 09/09/2026 | Verkauf | 530.23 | 522 | 276,781 | Form 4 |
| MDGL | Sibold William John | President and CEO | 09/09/2026 | Verkauf | 529.27 | 347 | 183,656 | Form 4 |
| MDGL | Sibold William John | President and CEO | 09/09/2026 | Verkauf | 527.88 | 131 | 69,152 | Form 4 |
| MDCX | Smith Andrew Alasdair | Chief Operating Officer | 09/04/2026 | Zuteilung | 0.1705 | 735,294 | 125,368 | Form 4 |
| MDCX | Mehmud Faisal | Chief Medical Officer | 09/04/2026 | Zuteilung | 0.1705 | 1,470,588 | 250,735 | Form 4 |
| MDCX | Brennan Edward J. | Chief Scientific Officer | 09/04/2026 | Zuteilung | 0.1705 | 588,235 | 100,294 | Form 4 |
| MDCX | Bonner Carolyn F. | President and CFO | 09/04/2026 | Zuteilung | 0.1705 | 1,470,588 | 250,735 | Form 4 |
| MDCX | Bokhari Raza | Chief Executive Officer | 09/04/2026 | Zuteilung | 0.1705 | 2,941,176 | 501,471 | Form 4 |
| MDLZ | Zaramella Luca | EVP & Chief Operating Officer | 09/02/2026 | Steuer-Abgabe | 62.45 | 18,695 | 1,167,503 | Form 4 |
| MDLZ | Zaramella Luca | EVP & Chief Operating Officer | 09/02/2026 | Optionsausübung | 43.20 | 22,570 | 975,024 | Form 4 |
| MDWD | Rubinstein Samuel | Director | 09/01/2026 | Kauf | 12.62 | 525 | 6,626 | Form 4 |
| MDWD | Rubinstein Samuel | Director | 09/01/2026 | Verkauf | 12.72 | 525 | 6,678 | Form 4 |
| MDWD | Hess Shmuel | COO & Chief Commercial Officer | 08/27/2026 | Verkauf | 13.13 | 1,979 | 25,976 | Form 4 |
| MDWD | Hess Shmuel | COO & Chief Commercial Officer | 08/26/2026 | Verkauf | 13.00 | 1,865 | 24,245 | Form 4 |
| MDT | Marinaro Michael | EVP, Pres MedSurg and Americas | 08/20/2026 | Steuer-Abgabe | 92.30 | 1,084 | 100,053 | Form 4 |
| MDLZ | Van de Put Dirk | Chief Executive Officer | 08/19/2026 | Verkauf | 64.08 | 133,580 | 8,559,806 | Form 4 |
| MDLZ | Van de Put Dirk | Chief Executive Officer | 08/19/2026 | Optionsausübung | 42.11 | 133,580 | 5,625,054 | Form 4 |
| MDGL | Kelley Shannon T | General Counsel | 08/17/2026 | Verkauf | 514.97 | 664 | 341,940 | Form 4 |
| MDB | Merriman Dwight A | Director | 08/17/2026 | Verkauf | 456.36 | 120 | 54,763 | Form 4 |
| MDB | Merriman Dwight A | Director | 08/17/2026 | Verkauf | 454.88 | 80 | 36,390 | Form 4 |
| MDB | Merriman Dwight A | Director | 08/17/2026 | Verkauf | 453.71 | 2,174 | 986,366 | Form 4 |
| MDB | Merriman Dwight A | Director | 08/17/2026 | Verkauf | 452.55 | 460 | 208,173 | Form 4 |
| MDB | Merriman Dwight A | Director | 08/17/2026 | Verkauf | 451.22 | 522 | 235,537 | Form 4 |
| MDB | Merriman Dwight A | Director | 08/17/2026 | Verkauf | 450.28 | 1,652 | 743,863 | Form 4 |
| MDB | Merriman Dwight A | Director | 08/17/2026 | Verkauf | 448.98 | 992 | 445,388 | Form 4 |
| MDGL | Reed John C | Director | 08/15/2026 | Zuteilung | — | 647 | — | Form 4 |
| MD | Young Sylvia Jean | Director | 08/14/2026 | Abgabe | 26.62 | 18,500 | 492,470 | Form 4 |
| MDB | Merriman Dwight A | Director | 08/14/2026 | Verkauf | 472.22 | 3,248 | 1,533,771 | Form 4 |
| MDB | Merriman Dwight A | Director | 08/14/2026 | Verkauf | 469.81 | 6,752 | 3,172,157 | Form 4 |
| MDLN | GIC Private Ltd | 10% Owner | 08/14/2026 | Verkauf | 35.80 | 100,000 | 3,580,000 | Form 4 |
| MDAI | DiMaio John Michael | Director | 08/13/2026 | Zuteilung | 1.64 | 35,000 | 57,400 | Form 4 |
| MDLN | GIC Private Ltd | 10% Owner | 08/13/2026 | Verkauf | 35.80 | 1,500,000 | 53,700,000 | Form 4 |
| MDXH | MVM Partners, LLC | Director | 08/13/2026 | Kauf | 0.454 | 2,202,643 | 1,000,000 | Form 4 |
| MD | McEachin Thomas | Director | 08/12/2026 | Zuteilung | 26.50 | 472 | 12,508 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).